However, our patients were included in the study based on confirmed alterations of KCNV2, while patients in the study of Hood et al. were chosen on a clinical-electrophysiological basis (i.e. retinal dystrophy with supernormal rod responses). The gene discussed is KCNV2; the disease is inherited retinal dystrophy.